Effect of cisplatin on renal brush border membrane enzymes and phosphate transport

被引:21
作者
Fatima, S [1 ]
Yusufi, ANK [1 ]
Mahmood, R [1 ]
机构
[1] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India
关键词
cisplatin; nephrotoxicity; brush border membrane; phosphate transport; brush border membrane enzymes;
D O I
10.1191/0960327104ht491oa
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Cisplatin (CDDP) is widely used in the treatment of various cancers but its clinical use is associated with dose limiting nephrotoxicity. The present work was carried out to study the effect of administration of CDDP on rat renal brush border membrane (BBM) marker enzymes and inorganic phosphate (Pi) transport across BBM vesicles (BBMV). Animals were administered a single intraperitoneal dose of CDDP ( 6 mg/kg body weight) or normal saline and then sacrificed 2, 4, 8 and 16 days after this treatment. The administration of CDDP resulted in increased serum creatinine and blood urea nitrogen levels and decreased activity of BBM marker enzymes in the BBM as well as in the homogenates of cortex and medulla. Kinetic studies showed that the V-max of the enzymes was decreased in BBM from CDDP treated rats while the K-m remained unchanged. The Na+-gradient dependent transport of Pi across BBMV was also significantly reduced after CDDP treatment. These results strongly suggest that the administration of a single nephrotoxic dose of CDDP results in impairment of the functions of renal BBM.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 41 条
[1]  
Booth A G, 1974, Biochem J, V142, P575
[2]  
CHENG L, 1981, J BIOL CHEM, V256, P1556
[3]  
CHOIE DD, 1981, LAB INVEST, V44, P397
[4]  
CHOPRA S, 1982, KIDNEY INT, V21, P54, DOI 10.1038/ki.1982.8
[5]  
COURJAULTGAUTIER F, 1994, J PHARMACOL EXP THER, V270, P1097
[6]  
CROCKER CL, 1967, AM J MED TECHNOL, V33, P361
[7]   METHOD FOR ASSAY OF INTESTINAL DISACCHARIDASES [J].
DAHLQVIST, A .
ANALYTICAL BIOCHEMISTRY, 1964, 7 (01) :18-&
[8]   CISPLATIN NEPHROTOXICITY - A REVIEW [J].
DAUGAARD, G ;
ABILDGAARD, U .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (01) :1-9
[9]  
DOBYAN DC, 1980, J PHARMACOL EXP THER, V213, P551
[10]  
Fink D, 2000, CANC DRUG DISC DEV, V7, P149